<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>getSimulationsObsDataFromProjects — getSimulationsObsDataFromProjects • ospsuite.qualificationplaneditor</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet"><link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet"><script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="getSimulationsObsDataFromProjects — getSimulationsObsDataFromProjects"><meta name="description" content="Get a data.frame of projects, simulations and observed data"><meta property="og:description" content="Get a data.frame of projects, simulations and observed data"></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">ospsuite.qualificationplaneditor</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.1.0</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="nav-item"><a class="nav-link" href="../articles/ospsuite-qualificationplaneditor.html">Get started</a></li>
<li class="active nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles"><li><a class="dropdown-item" href="../articles/excel-template.html">Excel Template</a></li>
    <li><a class="dropdown-item" href="../articles/no-qualification.html">Snapshot without a Qualification Plan</a></li>
    <li><a class="dropdown-item" href="../articles/snapshot-qualification.html">Add a Snapshot to my Qualification Plan</a></li>
    <li><a class="dropdown-item" href="../articles/update-qualification.html">Update my Qualification Plan Evaluations</a></li>
  </ul></li>
      </ul><ul class="navbar-nav"><li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json"></form></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/open-systems-pharmacology/ospsuite.qualificationplaneditor/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
      </ul></div>


  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">

      <h1>getSimulationsObsDataFromProjects</h1>
      <small class="dont-index">Source: <a href="https://github.com/open-systems-pharmacology/ospsuite.qualificationplaneditor/blob/main/R/utilities-excel-ui.R" class="external-link"><code>R/utilities-excel-ui.R</code></a></small>
      <div class="d-none name"><code>getSimulationsObsDataFromProjects.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>Get a data.frame of projects, simulations and observed data</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">getSimulationsObsDataFromProjects</span><span class="op">(</span><span class="va">projectData</span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>


<dl><dt id="arg-projectdata">projectData<a class="anchor" aria-label="anchor" href="#arg-projectdata"></a></dt>
<dd><p>A data.frame of project snapshots</p></dd>

</dl></div>
    <div class="section level2">
    <h2 id="value">Value<a class="anchor" aria-label="anchor" href="#value"></a></h2>
    <p>A data.frame with columns `Project`, `Simulation` and `ObservedData`</p>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># Get the project data from a list of paths</span></span></span>
<span class="r-in"><span><span class="va">snapshotPaths</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span></span></span>
<span class="r-in"><span>  <span class="st">"Raltegravir"</span> <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/file.path.html" class="external-link">file.path</a></span><span class="op">(</span></span></span>
<span class="r-in"><span>    <span class="st">"https://raw.githubusercontent.com"</span>,</span></span>
<span class="r-in"><span>    <span class="st">"Open-Systems-Pharmacology"</span>,</span></span>
<span class="r-in"><span>    <span class="st">"Raltegravir-Model"</span>,</span></span>
<span class="r-in"><span>    <span class="st">"v1.2"</span>,</span></span>
<span class="r-in"><span>    <span class="st">"Raltegravir-Model.json"</span></span></span>
<span class="r-in"><span>  <span class="op">)</span>,</span></span>
<span class="r-in"><span>  <span class="st">"Atazanavir"</span> <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/file.path.html" class="external-link">file.path</a></span><span class="op">(</span></span></span>
<span class="r-in"><span>    <span class="st">"https://raw.githubusercontent.com"</span>,</span></span>
<span class="r-in"><span>    <span class="st">"Open-Systems-Pharmacology"</span>,</span></span>
<span class="r-in"><span>    <span class="st">"Atazanavir-Model"</span>,</span></span>
<span class="r-in"><span>    <span class="st">"v1.2"</span>,</span></span>
<span class="r-in"><span>    <span class="st">"Atazanavir-Model.json"</span></span></span>
<span class="r-in"><span>  <span class="op">)</span></span></span>
<span class="r-in"><span><span class="op">)</span></span></span>
<span class="r-in"><span><span class="va">projectData</span> <span class="op">&lt;-</span> <span class="fu"><a href="getProjectsFromList.html">getProjectsFromList</a></span><span class="op">(</span><span class="va">snapshotPaths</span><span class="op">)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># Get the simulations Observed Data from the projects</span></span></span>
<span class="r-in"><span><span class="fu">getSimulationsObsDataFromProjects</span><span class="op">(</span><span class="va">projectData</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span>        Project                                         Simulation</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1  Raltegravir          Raltegravir 800 mg  (lactose formulation)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2  Raltegravir          Raltegravir 10 mg   (lactose formulation)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3  Raltegravir          Raltegravir 100 mg  (lactose formulation)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4  Raltegravir        Raltegravir 1200 mg   (lactose formulation)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 5  Raltegravir         Raltegravir 1600 mg  (lactose formulation)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6  Raltegravir         Raltegravir 200 mg   (lactose formulation)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7  Raltegravir           Raltegravir 25 mg  (lactose formulation)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8  Raltegravir           Raltegravir 50 mg  (lactose formulation)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9  Raltegravir                  Raltegravir 400mg chewable fasted</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10 Raltegravir                Raltegravir 400mg filmcoated tablet</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 11 Raltegravir                Raltegravir 400mg filmcoated tablet</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 12 Raltegravir                Raltegravir 400mg filmcoated tablet</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 13 Raltegravir            Raltegravir 400mg (lactose formulation)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 14 Raltegravir            Raltegravir 100 mg filmcoated tablet md</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 15 Raltegravir            Raltegravir 200 mg filmcoated tablet md</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 16 Raltegravir            Raltegravir 200 mg filmcoated tablet md</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 17 Raltegravir            Raltegravir 400 mg filmcoated tablet md</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 18 Raltegravir         Raltegravir 400mg (granules in suspension)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 19 Raltegravir                     Raltegravir 400mg chewable fed</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 20  Atazanavir                                   Acosta2007_300mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 21  Atazanavir                                 Agarwala2003_400mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 22  Atazanavir                                Agarwala2005a_400mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 23  Atazanavir                                Agarwala2005b_400mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 24  Atazanavir                                   Martin2008_400mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 25  Atazanavir                                      Zhu2011_400mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 26  Atazanavir                                      Zhu2011_400mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 27  Atazanavir   FDA-ClinPharmReview_AI424-014_400mg_YoungFemales</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 28  Atazanavir                FDA-ClinPharmReview_AI424-028_200mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 29  Atazanavir                FDA-ClinPharmReview_AI424-028_200mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 30  Atazanavir                FDA-ClinPharmReview_AI424-028_400mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 31  Atazanavir                FDA-ClinPharmReview_AI424-028_400mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 32  Atazanavir                FDA-ClinPharmReview_AI424-040_200mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 33  Atazanavir                FDA-ClinPharmReview_AI424-040_400mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 34  Atazanavir                FDA-ClinPharmReview_AI424-040_800mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 35  Atazanavir                FDA-ClinPharmReview_AI424-056_300mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 36  Atazanavir                FDA-ClinPharmReview_AI424-076_400mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 37  Atazanavir                FDA-ClinPharmReview_AI424-076_800mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 38  Atazanavir                           Zhu2010_300mg_Atazanavir</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 39  Atazanavir     FDA-ClinPharmReview_AI424-004_400mg_TreatmentA</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 40  Atazanavir     FDA-ClinPharmReview_AI424-014_400mg_YoungMales</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 41  Atazanavir     FDA-ClinPharmReview_AI424-014_400mg_YoungMales</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 42  Atazanavir FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                                                                                                   ObservedData</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1                                                      Iwamoto 2008 - 800mg - Raltegravir - PO - 800 mg - Plasma - agg. (n=24)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2                                                        Iwamoto 2008 - 10mg - Raltegravir - PO - 10 mg - Plasma - agg. (n=24)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3                                                      Iwamoto 2008 - 100mg - Raltegravir - PO - 100 mg - Plasma - agg. (n=24)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4                                                    Iwamoto 2008 - 1200mg - Raltegravir - PO - 1200 mg - Plasma - agg. (n=24)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 5                                                    Iwamoto 2008 - 1600mg - Raltegravir - PO - 1600 mg - Plasma - agg. (n=24)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6                                                      Iwamoto 2008 - 200mg - Raltegravir - PO - 200 mg - Plasma - agg. (n=24)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7                                                        Iwamoto 2008 - 25mg - Raltegravir - PO - 25 mg - Plasma - agg. (n=24)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8                                                        Iwamoto 2008 - 50mg - Raltegravir - PO - 50 mg - Plasma - agg. (n=24)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9                                        Rhee 2014 - Chewable tablet fasted - Raltegravir - po - 400 mg - Plasma - agg. (n=12)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10                                            Rhee 2014 - filmcoated tablet - Raltegravir - po - 400 mg - Plasma - agg. (n=12)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 11                                                     Wenning 2009 - 400mg - Raltegravir - PO - 400 mg - Plasma - agg. (n=10)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 12                                                 Iwamoto 2008 - 400mg FCT - Raltegravir - PO - 400 mg - Plasma - agg. (n=14)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 13                                                     Iwamoto 2008 - 400mg - Raltegravir - PO - 400 mg - Plasma - agg. (n=24)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 14                                             Markowitz 2006 - 100mg FCT MD - Raltegravir - PO - 100 mg - Plasma - agg. (n=7)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 15                                             Markowitz 2006 - 200mg FCT MD - Raltegravir - PO - 200 mg - Plasma - agg. (n=7)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 16                                              Kassahun 2007 - 200mg FCT SD - Raltegravir - PO - 200 mg - Plasma - agg. (n=8)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 17                                             Markowitz 2006 - 400mg FCT MD - Raltegravir - PO - 400 mg - Plasma - agg. (n=6)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 18                                          Rhee 2014 - granules suspension - Raltegravir - po - 400 mg - Plasma - agg. (n=12)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 19                                          Rhee 2014 - Chewable tablet fed - Raltegravir - po - 400 mg - Plasma - agg. (n=12)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 20                                                    Acosta 2007 - Period 1 - Atazanavir - PO - 300 mg - Plasma - agg. (n=10)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 21                                                     Agarwala 2003 - Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 22                                     Agarwala 2005a - ATV 400 mg AM (N=15) - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 23                                 Agarwala 2005b - ATV 400 mg (Treatment A) - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 24                             Martin 2008 - Atazanavir monotherapy (n = 24) - Atazanavir - PO - 400 mg - Plasma - agg. (n=24)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 25                             Zhu 2011 - Treatment A: Atazanavir 400 mg QPM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 26                             Zhu 2011 - Treatment B: Atazanavir 400 mg QAM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 27                         ClinPharmReview, AI424-014, p. 77 - Young Females - Atazanavir - PO - 400 mg - Plasma - agg. (n=14)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 28                               ClinPharmReview, AI424-028, p. 128 - A-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 29                               ClinPharmReview, AI424-028, p. 128 - B-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 30                               ClinPharmReview, AI424-028, p. 128 - C-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 31                               ClinPharmReview, AI424-028, p. 128 - D-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 32                                ClinPharmReview, AI424-040, p. 64 - 200 mg - Atazanavir - PO - 200 mg - Plasma - agg. (n=20)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 33                                ClinPharmReview, AI424-040, p. 64 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=20)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 34                                ClinPharmReview, AI424-040, p. 64 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=20)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 35 ClinPharmReview, AI424-056, p. 134 - Atazanavir without ritonavir, Day 10 - Atazanavir - PO - 300 mg - Plasma - agg. (n=30)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 36                               ClinPharmReview, AI424-076, p. 178 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 37                               ClinPharmReview, AI424-076, p. 178 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=66)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 38                                   Zhu 2010 - Atazanvir 300 mg twice daily - Atazanavir - PO - 300 mg - Plasma - agg. (n=22)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 39                           ClinPharmReview, AI424-004, p. 94 - Treatment A - Atazanavir - PO - 400 mg - Plasma - agg. (n=32)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 40                    ClinPharmReview, AI424-029, p. 47 - Urinary radioactivity - Atazanavir - PO - 400  - Urine - agg. (n=12)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 41                           ClinPharmReview, AI424-014, p. 77 - Young Males - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 42                       ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)</span>
<span class="r-in"><span></span></span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by Juri Solodenko, Pierre Chelle.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.2.0.</p>
</div>

    </footer></div>





  </body></html>

